跳至主要内容
临床试验/NCT04246060
NCT04246060Enrolling By Invitation不适用

Multicentre, Ambispective, Observational, Real Life Study to Assess the Quality of Life Effectiveness of Extended Release (ER) Oral Cysteamine Therapy (Procysbi) in Belgian Patients Suffering From Nephropathic Cystinosis

Chiesi SA/NV7 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2020年7月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
31
试验地点
7
主要终点
to descriptively assess the change from baseline and percent change from baseline in the quality of life overall summary sores at 12 months in switch cohort

研究概览

简要总结

Most of the real world evidence data related to efficacy of cysteamine therapy is retrospective. This study is a ambispective study to investigate the impact of cystine depletion therapy on the quality of life of patients and their parents.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Cohort 1

Patients on extended release cysteamine treatment at study enrollment

干预措施: Cysteamine Bitartrate (Drug)

Cohort 2

Patients switching from immediate release cysteamine to extended release cysteamine during the study

干预措施: Cysteamine Bitartrate (Drug)

Cohort 3

Patients remaining on immediate release cysteamine treatment

干预措施: Cysteamine Bitartrate (Drug)

结局指标

主要结局

to descriptively assess the change from baseline and percent change from baseline in the quality of life overall summary sores at 12 months in switch cohort

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
Chiesi SA/NV
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验